This study investigates the bioequivalence of a combination tablet containing two active ingredients, pyronaridine and artesunate, in healthy adults. Bioequivalence means that two drugs have similar bioavailability and effects on the body. The study compares a to-be-marketed tablet with a clinical trial reference tablet, both given as a single dose.
Participants in the study will receive a single dose of the investigational medication, which is a combination of pyronaridine and artesunate. The study will measure how the drug is absorbed, distributed, metabolized, and excreted in the body to determine if the two tablet forms are bioequivalent.
- Who can participate: Participants should be healthy adults, typically within a specific age range, as determined by the study's eligibility criteria.
- Study details: Participants will take a single dose of the investigational medication. The study will involve monitoring how the drug behaves in the body.
